Cargando…
Quantitative systems pharmacology modeling provides insight into inter‐mouse variability of Anti‐CTLA4 response
Clinical responses of immuno‐oncology therapies are highly variable among patients. Similar response variability has been observed in syngeneic mouse models. Understanding of the variability in the mouse models may shed light on patient variability. Using a murine anti‐CTLA4 antibody as a case study...
Autores principales: | Qiao, Wenlian, Lin, Lin, Young, Carissa, Narula, Jatin, Hua, Fei, Matteson, Andrew, Hooper, Andrea, Gruenbaum, Lore, Betts, Alison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286718/ https://www.ncbi.nlm.nih.gov/pubmed/35439371 http://dx.doi.org/10.1002/psp4.12800 |
Ejemplares similares
-
Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment
por: Ji, Yan, et al.
Publicado: (2023) -
Sources of inter-individual variability leading to significant changes in anti-PD-1 and anti-PD-L1 efficacy identified in mouse tumor models using a QSP framework
por: Leete, Jessica C., et al.
Publicado: (2022) -
Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology
por: Betts, Alison, et al.
Publicado: (2020) -
Quantitative analysis of intra- and inter-individual variability of human beta-cell mass
por: Olehnik, Scott K., et al.
Publicado: (2017) -
Individualized, discrete event, simulations provide insight into inter- and intra-subject variability of extended-release, drug products
por: Kim, Sean HJ, et al.
Publicado: (2012)